FLX475

FLX475 · RAPT Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for FLX475, covering 2023-12-05 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer [Phase 2]